238 related articles for article (PubMed ID: 15866343)
1. Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib.
Park K; Yang JH; Choi Y; Lee C; Kim SY; Byun Y
J Control Release; 2005 May; 104(1):167-79. PubMed ID: 15866343
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive efficacy of all-trans-retinoic acid in biodegradable microspheres against epithelial cancers: results in a 4-nitroquinoline 1-oxide-induced oral carcinogenesis model.
Choi Y; Kim SY; Park K; Yang J; Cho KJ; Kwon HJ; Byun Y
Int J Pharm; 2006 Aug; 320(1-2):45-52. PubMed ID: 16730144
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination.
Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563
[TBL] [Abstract][Full Text] [Related]
4. 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis.
Tanaka T; Makita H; Kawabata K; Mori H; El-Bayoumy K
Cancer Res; 1997 Sep; 57(17):3644-8. PubMed ID: 9288763
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
6. Histological and immunohistochemical evaluation of the chemopreventive role of lycopene in tongue carcinogenesis induced by 4-nitroquinoline-1-oxide.
El-Rouby DH
Arch Oral Biol; 2011 Jul; 56(7):664-71. PubMed ID: 21216390
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Yamamoto K; Kitayama W; Denda A; Morisaki A; Kuniyasu H; Inoue M; Kirita T
Exp Toxicol Pathol; 2004 Dec; 56(3):145-51. PubMed ID: 15625783
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene.
Tanaka T; Makita H; Ohnishi M; Hirose Y; Wang A; Mori H; Satoh K; Hara A; Ogawa H
Cancer Res; 1994 Sep; 54(17):4653-9. PubMed ID: 8062259
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases.
Tanaka T; Kawamori T; Ohnishi M; Okamoto K; Mori H; Hara A
Cancer Res; 1994 May; 54(9):2359-65. PubMed ID: 8162581
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide.
Shiotani H; Denda A; Yamamoto K; Kitayama W; Endoh T; Sasaki Y; Tsutsumi N; Sugimura M; Konishi Y
Cancer Res; 2001 Feb; 61(4):1451-6. PubMed ID: 11245450
[TBL] [Abstract][Full Text] [Related]
11. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies.
Suzuki R; Kohno H; Suzui M; Yoshimi N; Tsuda H; Wakabayashi K; Tanaka T
Carcinogenesis; 2006 Mar; 27(3):619-30. PubMed ID: 16219633
[TBL] [Abstract][Full Text] [Related]
12. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
Fong LY; Zhang L; Jiang Y; Farber JL
J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin.
Makita H; Tanaka T; Fujitsuka H; Tatematsu N; Satoh K; Hara A; Mori H
Cancer Res; 1996 Nov; 56(21):4904-9. PubMed ID: 8895742
[TBL] [Abstract][Full Text] [Related]
14. Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
Yamamoto K; Kitayama W; Denda A; Sasahira T; Kuniyasu H; Kirita T
Pathobiology; 2006; 73(6):317-24. PubMed ID: 17374970
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris RE; Alshafie GA; Abou-Issa H; Seibert K
Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
[TBL] [Abstract][Full Text] [Related]
16. Dietary garcinol inhibits 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats.
Yoshida K; Tanaka T; Hirose Y; Yamaguchi F; Kohno H; Toida M; Hara A; Sugie S; Shibata T; Mori H
Cancer Lett; 2005 Apr; 221(1):29-39. PubMed ID: 15797624
[TBL] [Abstract][Full Text] [Related]
17. The effect of dietary and topical celecoxib on 4-nitroquinoline-1-oxide-induced lingual epithelium alternations in rat.
Sohrabi M; Soleimani J; Roshangar L; Vatansever S; Arbabi F; Khaki AA; Abbasi MM; Dustar Y; Javadzadeh Y
J Pak Med Assoc; 2009 Nov; 59(11):769-74. PubMed ID: 20361677
[TBL] [Abstract][Full Text] [Related]
18. A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Makita H; Mutoh M; Maruyama T; Yonemoto K; Kobayashi A; Fujitsuka H; Toida M; Shibata T; Miyamoto S; Yasui Y; Suzuki R; Wakabayashi K; Tanaka T
Carcinogenesis; 2007 Mar; 28(3):677-84. PubMed ID: 17052996
[TBL] [Abstract][Full Text] [Related]
19. A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies.
Miyamoto S; Yasui Y; Kim M; Sugie S; Murakami A; Ishigamori-Suzuki R; Tanaka T
Carcinogenesis; 2008 Feb; 29(2):418-26. PubMed ID: 18174262
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin.
Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A
Cancer Res; 1995 Sep; 55(18):4059-64. PubMed ID: 7664280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
